Private Advisor Group, LLC Biogen Inc. Transaction History

Private Advisor Group, LLC

$15.6 Billion
Q3 2024

A detailed history of Private Advisor Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 9,645 shares of BIIB stock, worth $1.68 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,645

Previous 8,721 10.6%

Holding current value

$1.68 Million

Previous $2.02 Million 7.52%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$189.07 - $236.8 $174,700 - $218,803	924 Added 10.6%	9,645 $1.87 Million
Q2 2024 Aug 05, 2024	BUY	$190.52 - $236.72 $740,741 - $920,367	3,888 Added 80.45%	8,721 $2.02 Million
Q1 2024 Apr 30, 2024	BUY	$212.02 - $267.71 $47,492 - $59,967	224 Added 4.86%	4,833 $1.04 Million
Q4 2023 Feb 06, 2024	SELL	$222.59 - $267.94 $4,451 - $5,358	-20 Reduced 0.43%	4,609 $1.19 Million
Q3 2023 Nov 02, 2023	BUY	$253.3 - $285.89 $24,570 - $27,731	97 Added 2.14%	4,629 $1.19 Million
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $3,027 - $3,498	11 Added 0.24%	4,532 $1.29 Million
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $390,997 - $445,526	-1,524 Reduced 25.21%	4,521 $1.26 Million
Q4 2022 Jan 18, 2023	BUY	$252.44 - $306.72 $451,110 - $548,108	1,787 Added 41.97%	6,045 $0
Q3 2022 Oct 14, 2022	SELL	$194.69 - $268.46 $435,716 - $600,813	-2,238 Reduced 34.45%	4,258 $1.14 Million
Q2 2022 Jul 13, 2022	BUY	$187.54 - $223.02 $147,969 - $175,962	789 Added 13.83%	6,496 $1.33 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $85,258 - $107,421	-440 Reduced 7.16%	5,707 $1.2 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $8.13 Million - $10.5 Million	-36,314 Reduced 85.52%	6,147 $1.48 Million
Q3 2021 Oct 14, 2021	BUY	$282.99 - $369.05 $9.81 Million - $12.8 Million	34,676 Added 445.42%	42,461 $12 Million
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $26,936 - $43,129	104 Added 1.35%	7,785 $2.7 Million
Q1 2021 Apr 22, 2021	BUY	$242.95 - $284.63 $331,383 - $388,235	1,364 Added 21.59%	7,681 $2.15 Million
Q4 2020 Apr 01, 2021	SELL	$236.26 - $355.63 $68,751 - $103,488	-291 Reduced 4.4%	6,317 $1.55 Million
Q3 2020 Nov 02, 2020	SELL	$264.77 - $305.71 $189,840 - $219,194	-717 Reduced 9.79%	6,608 $1.83 Million
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $263,833 - $349,401	1,020 Added 16.18%	7,325 $1.96 Million
Q1 2020 May 12, 2020	BUY	$268.85 - $341.04 $100,012 - $126,866	372 Added 6.27%	6,305 $2 Million
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $931,734 - $1.29 Million	-4,234 Reduced 41.64%	5,933 $1.76 Million
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $1.07 Million - $1.2 Million	4,908 Added 93.33%	10,167 $2.64 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $33,551 - $36,983	153 Added 3.0%	5,259 $1.23 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $22,321 - $34,912	103 Added 2.06%	5,106 $1.21 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $621,890 - $787,690	-2,233 Reduced 30.86%	5,003 $1.5 Million
Q3 2018 Nov 01, 2018	SELL	$293.51 - $383.83 $4.46 Million - $5.83 Million	-15,190 Reduced 67.73%	7,236 $2.56 Million
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $5.17 Million - $6.17 Million	20,093 Added 861.25%	22,426 $6.53 Million
Q1 2018 May 09, 2018	SELL	$260.13 - $367.91 $723,941 - $1.02 Million	-2,783 Reduced 54.4%	2,333 $642,000
Q4 2017 Feb 07, 2018	SELL	$307.64 - $344.58 $526,372 - $589,576	-1,711 Reduced 25.06%	5,116 $1.68 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $384,613 - $451,015	1,368 Added 25.06%	6,827 $2.23 Million
Q2 2017 Aug 10, 2017	BUY	N/A	5,459	5,459 $1.49 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Biogen Inc. Transaction History